Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.
Read Full NewsLong-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
1.
Charles III, King of Kings, is Cancerous.
2.
Males with early-onset colorectal cancer are at risk, according to a study.
3.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
4.
Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.
5.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
1.
Unlocking the Potential of Polatuzumab for Cancer Treatment
2.
Lymphomatoid Papulosis: What You Need to Know
3.
Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling
4.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
5.
Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge